|
Markey, Mia K |
University Of Texas At Austin |
3-D modeling-based decision support for optimizing quality of life following breast reconstruction |
PA-13-302: Research Project Grant |
|
Salvemini, Daniela |
Saint Louis University |
A3AR agonists as a novel approach to mitigate chemotherapy induced neurotoxicity |
PAR-16-275: Serious Adverse Drug Reaction Research |
|
Mosher, Catherine E |
Indiana Univ-Purdue Univ At Indianapolis |
Acceptance and Commitment Therapy for Fatigue Interference in Metastatic Breast Cancer |
PAR-18-559: Cancer Prevention and Control Clinical Trials Grant Program |
|
Cheville, Andrea Lynne |
Mayo Clinic Rochester |
Achieving Equity through SocioCulturally-informed, Digitally-Enabled Cancer Pain managemeNTā (ASCENT) Clinical Trial |
RFA-NS-22-002: HEAL Initiative: Advancing Health Equity in Pain Management |
|
Schenker, Yael |
University Of Pittsburgh At Pittsburgh |
A cluster randomized trial of a primary palliative care intervention (CONNECT) for patients with advanced cancer |
PA-13-302: Research Project Grant |
|
Yennu, Sriram |
University Of Tx Md Anderson Can Ctr |
A Combination Therapy to Treat Cancer-Related Fatigue |
PAR-18-559: Cancer Prevention and Control Clinical Trials Grant Program |
|
Bao, Ting |
Sloan-Kettering Inst Can Research |
Acupuncture for Chemothrapy-induced Peripheral Neuropathy Treatment (ACT)Trial |
PA-18-141: Mechanisms, Models, Measurement, and Management in Pain Research |
|
Reese, Jennifer Barsky |
Research Inst Of Fox Chase Can Ctr |
Addressing Sexual Concerns in Breast Cancer Survivors: RCT of a Novel Couple-Based Intervention |
PA-16-160: NIH Research Project Grant |
|
Tighiouart, Mourad |
Cedars-Sinai Medical Center |
Advancing Analysis and Interpretation ofAdverse Events and PROs in Cancer Clinical Trials |
RFA-CA-17-052: Analyzing and Interpreting Clinician and Patient Adverse Event Data to Better Understand Tolerability |
|
Somers, Tamara J |
Duke University |
A Mobile Health Behavioral Pain Intervention Protocol for Breast Cancer Patients with Pain in Medically Underserved Communities: A Randomized Controlled Trial |
PA-18-141: Mechanisms, Models, Measurement, and Management in Pain Research |
|
Wen, Kuang-Yi |
Thomas Jefferson University |
A Mobile TXT-based Intervention to Improve Adherence to Adjuvant Hormone Therapy and Symptom Management for BCa Survivors |
PA-18-004: Oral Anticancer Agents: Utilization, Adherence, and Health Care Delivery |
|
Wang, Hsiao-Lan |
University Of Alabama At Birmingham |
A Motion Exergaming Approach to Promote Self-Managing Fatigue and Pain after Head and Neck Cancer Treatment |
PA-21-268: Change of Recipient Organization (Type 7 Parent Clinical Trial Optional) |
|
Sharafeldin, Noha |
University Of Alabama At Birmingham |
A multi-component non-pharmacological intervention to improve cognitive outcomes in hematologic cancer survivors |
PAR-20-052: NCI Small Grants Program for Cancer Research for Years 2020, 2021, and 2022 |
|
Gray, Robert J |
Dana-Farber Cancer Inst |
Analysis of ECOG-ACRIN adverse event data to optimize strategies for the longitudinal assessment of tolerability in the context of evolving cancer treatment paradigms (EVOLV) |
RFA-CA-17-052: Analyzing and Interpreting Clinician and Patient Adverse Event Data to Better Understand Tolerability |
|
Basch, Ethan M. |
Univ Of North Carolina Chapel Hill |
Analyzing and Interpreting PRO-CTCAE with CTCAE and Other Clinical Data to Characterize Drug Tolerability |
RFA-CA-17-052: Analyzing and Interpreting Clinician and Patient Adverse Event Data to Better Understand Tolerability |
